Anti-HGF Receptor, c-Met, Human, Goat-Poly, Biotin

データシート※最新のデータシートでない場合があります

• 商品コード：BAF358
• メーカー：RSD
• 包装：50μg
• 価格： ¥93,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Burgess T et al. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors. Cancer Res. 2006 Feb;66(3):1721-9
  Burgess T et al
  2006/01/01
  
• 備考：
  human PC3 prostate cancer cell line
• 参照：
  

• No.： 2
• 文献情報：
  Athauda G et al. c-Met ectodomain shedding rate correlates with malignant potential. Clin. Cancer Res. 2006 Jul;12(14 Pt 1):4154-62
  Athauda G et al
  2006/01/01
  
• 備考：
  Species: Human, Application: Electrochemiluminescence, Sample type: Cell Supernates
• 参照：
  

• No.： 3
• 文献情報：
  Bellon SF et al. c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J. Biol. Chem. 2008 Feb;283(5):2675-83
  Bellon SF et al
  2008/01/01
  
• 備考：
  Species: Human, Application: ELISA Development, Sample type: Cell Lysates
• 参照：
  

• No.： 4
• 文献情報：
  Coxon A et al. Soluble c-Met receptors inhibit phosphorylation of c-Met and growth of hepatocyte growth factor: c-Met-dependent tumors in animal models. Mol. Cancer Ther. 2009 May;
  Coxon A et al
  2009/01/01
  
• 備考：
  Application: Electrochemiluminescence, Sample Type: Cell Lysates
• 参照：
  

• No.： 5
• 文献情報：
  Gordon MS et al. Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors. Clin. Cancer Res. 2010 Jan;16(2):699-710
  Gordon MS et al
  2010/01/01
  
• 備考：
  Application: Meso Scale Discovery ECL Assay, Sample Type: Plasma (Not Specified)
• 参照：
  

• No.： 6
• 文献情報：
  Cen B et al. The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling. Mol. Cell. Biol. 2014 Jul;34(13):2517-32
  Cen B et al
  2014/01/01
  
• 備考：
  Application: Western Blot, Sample Type: Cell Lysates
• 参照：
  

• No.： 7
• 文献情報：
  Tabernero J et al. A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases. Clin. Cancer Res. 2014 May;20(10):2793-804
  Tabernero J et al
  2014/01/01
  
• 備考：
  Application: ELISA Capture, Sample Type: Serum
• 参照：
  

• No.： 8
• 文献情報：
  Kaye DR et al. Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer. PLoS ONE 2016;11(6):e0157130
  Kaye DR et al
  2016/01/01
  
• 備考：
  Application: ELISA Capture, Sample Type: Plasma,Whole Tissue
• 参照：
  

• No.： 9
• 文献情報：
  Li W et al. Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering. Sci Rep 2019 Feb;9(1):1988
  Li W et al
  2019/01/01
  
• 備考：
  
• 参照：